





Ready to analyze markets, shape strategy, and influence decisions that can improve patients’ lives? At Amgen, we’re driven by one mission: to serve patients. As one of the world’s leading biotechnology companies, we bring innovative therapies to people with serious diseases — and we do that by grounding every strategic decision in solid economic and analytical insights. In the Netherlands, Amgen operates right where science, healthcare policy, and market access meet — a unique playground for students who want to understand how economic decisions influence which medicines reach patients and why. And now, our Legacy & Biosimilars (L&B) Franchise Team is looking for a final-year student ready to take on a high‑impact, analytical, strategic assignment. LIVE This could be your everyday Join a team working at the intersection of economics, strategy, and healthcare innovation, and take the lead on an assignment that genuinely matters: Your Mission Conduct a full market opportunity analysis to determine whether it makes strategic sense for Amgen to revitalize and re-invest in Aranesp within the nephrology market. You will explore: * Market size & competitive landscape * Feasibility of re-entry * Financial impact & potential ROI * Pricing, reimbursement, and health-economic considerations * Strategic risks & opportunities Your research and insights will directly support management decisions — a rare opportunity for a student to influence real business strategy. This is not just theoretical work: it’s your chance to connect economics, healthcare systems, and data analytics in a meaningful, purposeful environment. Deliverables Throughout your internship, you will produce: * A structured market and economic analysis * Data-driven insights using quantitative methods * A strategic assessment of whether to rebrand/promote/sell Aranesp again within nephrology * A recommendation report for L&B leadership supported by evidence and modeling This is the type of assignment that becomes a standout piece in a graduation thesis or portfolio.